Real-world outcomes of pulmonary mucormycosis in southeastern China: clinical characteristics and factors associated with mortality

Pulmonary mucormycosis (PM) is a life-threatening fungal infection, but regional data on its clinical characteristics and prognostic factors remain limited. We investigated the clinical features, microbiological findings, and factors associated with mortality in patients with PM in southeastern China. Methods: This retrospective cohort study included 72 adults hospitalized with PM at two hospitals in southeastern China between January 2013 and October 2025. Survival status was assessed at 3 months after discharge. Factors associated with mortality were examined using multivariable logistic regression. Model discrimination was assessed using receiver operating characteristic analysis, and a nomogram was developed. The median age was 59 years, and 69.4% of patients were male. Diabetes mellitus (43.1%) and hematologic malignancy (25.0%) were the most common underlying diseases. Rhizopus was the predominant genus, identified in 58.1% of the 43 patients with genus- or species-level identification. At follow-up, 33 patients (45.8%) were classified as non-survivors. Older age (adjusted odds ratio [aOR], 1.06; 95% confidence interval [CI], 1.00–1.12), dyspnea (aOR, 19.27; 95% CI, 4.10–90.52), and pulmonary nodules (aOR, 5.02; 95% CI, 1.10–22.87) were independently associated with increased odds of mortality, whereas higher lymphocyte counts were associated with lower odds (aOR, 0.28; 95% CI, 0.08–0.94). The five-variable model yielded an apparent area under the curve of 0.921. A separate four-variable nomogram incorporated age, dyspnea, pulmonary nodules, and lymphocyte count. Nearly half of the patients with PM died at follow-up. Older age, dyspnea, pulmonary nodules, and lower lymphocyte counts were independently associated with mortality. Routinely available clinical features may help identify high-risk patients.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2026-11-18
DOI
https://doi.org/10.1186/s12879-026-14868-1
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Real-world outcomes of pulmonary mucormycosis in southeastern China: clinical characteristics and factors associated with mortality

Kaixiong Liu, Li-Da Chen, Xiaobin Zhang, Jiamin Luo et al.
1 links
BMC Infectious Diseases
Antifungal resistance and susceptibility
article

Real-world outcomes of pulmonary mucormycosis in southeastern China: clinical characteristics and factors associated with mortality

Kaixiong Liu, Li-Da Chen, Xiaobin Zhang, Jiamin Luo, Zhi-Ming Cai, You-Wei Wu, Li Lin, Shu-Ting Chen, Wen-Sen Huang
article en

Abstract

Pulmonary mucormycosis (PM) is a life-threatening fungal infection, but regional data on its clinical characteristics and prognostic factors remain limited. We investigated the clinical features, microbiological findings, and factors associated with mortality in patients with PM in southeastern China. Methods: This retrospective cohort study included 72 adults hospitalized with PM at two hospitals in southeastern China between January 2013 and October 2025. Survival status was assessed at 3 months after discharge. Factors associated with mortality were examined using multivariable logistic regression. Model discrimination was assessed using receiver operating characteristic analysis, and a nomogram was developed. The median age was 59 years, and 69.4% of patients were male. Diabetes mellitus (43.1%) and hematologic malignancy (25.0%) were the most common underlying diseases. Rhizopus was the predominant genus, identified in 58.1% of the 43 patients with genus- or species-level identification. At follow-up, 33 patients (45.8%) were classified as non-survivors. Older age (adjusted odds ratio [aOR], 1.06; 95% confidence interval [CI], 1.00–1.12), dyspnea (aOR, 19.27; 95% CI, 4.10–90.52), and pulmonary nodules (aOR, 5.02; 95% CI, 1.10–22.87) were independently associated with increased odds of mortality, whereas higher lymphocyte counts were associated with lower odds (aOR, 0.28; 95% CI, 0.08–0.94). The five-variable model yielded an apparent area under the curve of 0.921. A separate four-variable nomogram incorporated age, dyspnea, pulmonary nodules, and lymphocyte count. Nearly half of the patients with PM died at follow-up. Older age, dyspnea, pulmonary nodules, and lower lymphocyte counts were independently associated with mortality. Routinely available clinical features may help identify high-risk patients.

BMC Infectious Diseases
Fujian Medical University (CN), Xiamen University (CN), First Affiliated Hospital of Fujian Medical University (CN), Zhongshan Hospital of Xiamen University (CN)
Natural Science Foundation of Fujian Province
Good health and well-being
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon